| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RADIUS HEALTH | 5,831,253 | 214,299,000 | 69.51% | ||
| 2 | Syndax Pharmaceuticals Inc | 2,168,691 | 21,362,000 | 6.93% | ||
| 3 | EPIZYME INC COM | 1,729,674 | 17,712,000 | 5.75% | ||
| 4 | CHIASMA INC | 5,736,296 | 16,578,000 | 5.38% | ||
| 5 | ENDOLOGIX INC | 1,121,447 | 13,973,000 | 4.53% | ||
| 6 | Proteon Therapeutics | 983,381 | 7,897,000 | 2.56% | ||
| 7 | ARATANA THERAPEUTICS INC COM | 1,117,875 | 7,065,000 | 2.29% | ||
| 8 | NEVRO CORP | 72,413 | 5,341,000 | 1.73% | ||
| 9 | CONATUS PHARMACEUTICALS INC COM | 1,192,080 | 2,456,000 | 0.80% | ||
| 10 | MAST THERAPEUTICS | 2,551,851 | 1,199,000 | 0.39% | ||
| 11 | COLUCID PHARMACEUTICALS INC COM | 21,806 | 178,000 | 0.06% | ||
| 12 | SANGAMO BIOSCIENCES INCORPORATED | 22,487 | 130,000 | 0.04% | ||
| 13 | MACROGENICS INC | 3,168 | 86,000 | 0.03% | ||
| 14 | ENTEROMEDICS INC | 74,215 | 22,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-018966, filed 2016.08.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
